Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Antimalarial agents: mechanisms of action.

Antimalarial agents: mechanisms of action. Receive: RSS Feeds, eTOCs, free email alerts (when new articles cite this article), more» Information about commercial reprint orders: http://aac.asm.org/site/misc/reprints.xhtml To subscribe to to another ASM Journal go to: http://journals.asm.org/site/subscriptions/ ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, June 1988, p. 793-798 0066-4804/88/060793-06$02.00/0 Copyright © 1988, American Society for Microbiology Vol. 32, No. 6 PAUL H. SCHLESINGER,' DONALD J. KROGSTAD,2"3* AND BARBARA L. HERWALDT2 Departments of Medicine2 and Pathology,3 Washington University School of Medicine, 660 South Euclid Avenue, and Department of Biomedical Research, Washington University School of Dental Medicine,' St. Louis, Missouri 63110 INTRODUCTION Global impact of malaria. The data available suggest that there are 200 million to 300 million cases of malaria, with more than 2 million deaths, each year (70). Most deaths result from Plasmodium falciparum infection in Africa and are among children less than 5 years of age. The numbers of malaria cases and deaths dwarf those of virtually all other infectious diseases, including human immunodeficiency virus infection. Plasmodia that infect humans. Four species of malaria parasites infect humans: P. falciparum, P. vivax, P. ovale, and P. malariae. Of these, only P. falciparum poses a significant risk of death in the nonimmune patient, because of its ability to invade http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Antimicrobial Agents and Chemotherapy American Society For Microbiology

Antimalarial agents: mechanisms of action.

Antimalarial agents: mechanisms of action.

Antimicrobial Agents and Chemotherapy , Volume volume 32 (issue 6) – Jun 1, 1988

Abstract

Receive: RSS Feeds, eTOCs, free email alerts (when new articles cite this article), more» Information about commercial reprint orders: http://aac.asm.org/site/misc/reprints.xhtml To subscribe to to another ASM Journal go to: http://journals.asm.org/site/subscriptions/ ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, June 1988, p. 793-798 0066-4804/88/060793-06$02.00/0 Copyright © 1988, American Society for Microbiology Vol. 32, No. 6 PAUL H. SCHLESINGER,' DONALD J. KROGSTAD,2"3* AND BARBARA L. HERWALDT2 Departments of Medicine2 and Pathology,3 Washington University School of Medicine, 660 South Euclid Avenue, and Department of Biomedical Research, Washington University School of Dental Medicine,' St. Louis, Missouri 63110 INTRODUCTION Global impact of malaria. The data available suggest that there are 200 million to 300 million cases of malaria, with more than 2 million deaths, each year (70). Most deaths result from Plasmodium falciparum infection in Africa and are among children less than 5 years of age. The numbers of malaria cases and deaths dwarf those of virtually all other infectious diseases, including human immunodeficiency virus infection. Plasmodia that infect humans. Four species of malaria parasites infect humans: P. falciparum, P. vivax, P. ovale, and P. malariae. Of these, only P. falciparum poses a significant risk of death in the nonimmune patient, because of its ability to invade

Loading next page...
 
/lp/american-society-for-microbiology/antimalarial-agents-mechanisms-of-action-xH4AUCUogb

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Society For Microbiology
Copyright
Copyright © 1988 by the American society for Microbiology.
ISSN
0066-4804
eISSN
1098-6596
Publisher site
See Article on Publisher Site

Abstract

Receive: RSS Feeds, eTOCs, free email alerts (when new articles cite this article), more» Information about commercial reprint orders: http://aac.asm.org/site/misc/reprints.xhtml To subscribe to to another ASM Journal go to: http://journals.asm.org/site/subscriptions/ ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, June 1988, p. 793-798 0066-4804/88/060793-06$02.00/0 Copyright © 1988, American Society for Microbiology Vol. 32, No. 6 PAUL H. SCHLESINGER,' DONALD J. KROGSTAD,2"3* AND BARBARA L. HERWALDT2 Departments of Medicine2 and Pathology,3 Washington University School of Medicine, 660 South Euclid Avenue, and Department of Biomedical Research, Washington University School of Dental Medicine,' St. Louis, Missouri 63110 INTRODUCTION Global impact of malaria. The data available suggest that there are 200 million to 300 million cases of malaria, with more than 2 million deaths, each year (70). Most deaths result from Plasmodium falciparum infection in Africa and are among children less than 5 years of age. The numbers of malaria cases and deaths dwarf those of virtually all other infectious diseases, including human immunodeficiency virus infection. Plasmodia that infect humans. Four species of malaria parasites infect humans: P. falciparum, P. vivax, P. ovale, and P. malariae. Of these, only P. falciparum poses a significant risk of death in the nonimmune patient, because of its ability to invade

Journal

Antimicrobial Agents and ChemotherapyAmerican Society For Microbiology

Published: Jun 1, 1988

There are no references for this article.